Nuwellis (NUWE) Return on Capital Employed (2012 - 2026)
Nuwellis (NUWE) reported Return on Capital Employed of 184.59% for Q1 2026, down 2105.0% on a YoY basis from 9.21% in Q1 2025, and down 101.7% quarter-over-quarter from 91.52% in Q4 2025.
Nuwellis (NUWE) Return on Capital Employed (2012 - 2026) Analysis & Trends
Nuwellis has reported Return on Capital Employed for 15 years, with the latest figure at 184.59% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 2105.0% year-over-year to 184.59%; the trailing twelve-month figure through Mar 2026 stood at 184.59% (down 2105.0% YoY), and the FY2025 full-year result was 74.17%, up 7722.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 184.59%, down from 91.52% in the prior quarter.
- The five-year high for Return on Capital Employed was 31.78% in Q3 2024, with the low at 234.74% in Q2 2025.
- Historically, Return on Capital Employed has averaged 80.6% across 5 years, with a median of 42.36% in 2023.
- The largest YoY upside for Return on Capital Employed was 10001 bps in 2025 against a maximum downside of 24973 bps in 2025.
- Nuwellis' Return on Capital Employed stood at 18.07% in 2022, then sank by 216 bps to 57.1% in 2023, then tumbled by 235 bps to 191.53% in 2024, then soared by 52 bps to 91.52% in 2025, then plunged by 102 bps to 184.59% in 2026.
- The last three Return on Capital Employed figures came in at 184.59% (Q1 2026), 91.52% (Q4 2025), and 217.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | -184.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -184.59% |
| Dec 31, 2025 | -91.52% |
| Sep 30, 2025 | -217.95% |
| Jun 30, 2025 | -234.74% |
| Mar 31, 2025 | -163.54% |
| Dec 31, 2024 | -191.53% |
| Sep 30, 2024 | 31.78% |
| Jun 30, 2024 | -18.18% |
| Mar 31, 2024 | -80.66% |
| Dec 31, 2023 | -57.10% |
| Sep 30, 2023 | -42.36% |
| Jun 30, 2023 | -39.45% |
| Mar 31, 2023 | -25.66% |
| Dec 31, 2022 | -18.07% |
| Sep 30, 2022 | -9.34% |
| Jun 30, 2022 | -13.99% |
| Mar 31, 2022 | -13.30% |
| Dec 31, 2021 | -14.19% |
| Sep 30, 2021 | -20.58% |
| Jun 30, 2021 | -17.08% |